New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
08:08 EDTACTActavis completes divestiture of generics commercial operations in 7 markets
Actavis announced that it has successfully completed the divestiture of its generics commercial operations in seven markets in Western Europe to Aurobindo Pharma. The agreement to divest the commercial operations was announced in January. Aurobindo acquired Actavis' pharmaceutical commercial infrastructure in France, Italy, Spain, Portugal, Belgium, Germany and the Netherlands, including products, marketing authorizations and dossier license rights. The two companies also entered into a long-term strategic supply arrangement.
News For ACT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ACT

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use